JS, L., A, M. P., EB, K., AJ, Y., O, N., S, M., . . . SP, H. (2025). Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy. Blood advances, 9(16), 4190. https://doi.org/10.1182/bloodadvances.2025016748
Chicago Style (17th ed.) CitationJS, Little, et al. "Invasive Fungal Disease Is Rare in Patients with Relapsed/refractory Multiple Myeloma Treated with BCMA CAR T-cell Therapy." Blood Advances 9, no. 16 (2025): 4190. https://doi.org/10.1182/bloodadvances.2025016748.
MLA (9th ed.) CitationJS, Little, et al. "Invasive Fungal Disease Is Rare in Patients with Relapsed/refractory Multiple Myeloma Treated with BCMA CAR T-cell Therapy." Blood Advances, vol. 9, no. 16, 2025, p. 4190, https://doi.org/10.1182/bloodadvances.2025016748.